Clinical experience with triethylene thiophosphoramide, with special reference to carcinoma of the breast.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D002277:Carcinoma; D006801:Humans; D013852:Thiotepa
D000970:Antineoplastic Agents; D013852:Thiotepa
BREAST NEOPLASMS/therapy; CYTOTOXIC DRUGS/therapeutic use